Attenuating Spinal Cord Injury by Conditioned Medium from Bone Marrow Mesenchymal Stem Cells

Area of Science:

• Regenerative Medicine
• Neuroscience
• Cell Biology

Background:

• Spinal cord injury (SCI) is a severe condition with limited effective treatments.
• Bone marrow mesenchymal stem cells (BM-MSCs) show therapeutic potential for SCI, primarily through paracrine effects.
• Cell-free therapy using MSC-conditioned medium (MSCcm) is being explored as an alternative to cell transplantation.

Purpose of the Study:

• To investigate the efficacy of systemically administered MSCcm as a potential treatment for SCI.
• To evaluate the impact of MSCcm on neuronal survival, axon regeneration, and functional recovery post-SCI.
• To explore the underlying molecular mechanisms, including autophagy and survival protein expression.

Main Methods:

• In vitro: Neuron-glial cultures were used to assess MSC coculture and MSCcm effects on neuronal survival and damage.
• In vivo: Rats with SCI received intravenous administration of MSCcm.
• Assessments included behavioral recovery tests, axon density quantification, and Western blot analysis of key proteins (Olig 2, HSP70, autophagy-related proteins).

Main Results:

• MSCcm promoted neuronal connections and reduced cell damage in vitro.
• Intravenous MSCcm administration significantly improved behavioral recovery and increased axon density in SCI rats.
• MSCcm treatment upregulated Olig 2, HSP70, and autophagy-related proteins in injured spinal cords.

Conclusions:

• Systemic administration of MSCcm is a promising cell-free therapeutic strategy for spinal cord injury.
• MSCcm treatment facilitates functional recovery and axon regeneration after SCI.
• The therapeutic effects may involve the activation of autophagy and enhancement of survival-related proteins.